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On March 30th, 2021, the heads of state of 25 nations, joined by the World Health Organization
(WHO), called for an international treaty on pandemic prevention and preparedness—the
highest level of political action to avert and respond to future health crises.1 In an historic
action, 194 countries passed a World Health Assembly (WHA) resolution to host a special
session devoted solely to an international pandemic agreement, now scheduled for November
29th.2 The WHA special session will be preceded by the United Nations General Assembly and
the G-20 group of nations. WHO Director-General Tedros Ghebreyesus referred to these 3
events as critical in shaping global health security.3 Georgetown University’s O’Neill Institute,
partnering with the Foundation of the National Institutes of Health, is hosting international
expert consultations to support WHO and its member states in the development of an
international agreement on pandemic prevention and preparedness.
Gaps in Global Governance
The response to the unfolding COVID-19 pandemic has exposed severe limitations in both the
International Health Regulations (IHR) and WHO’s institutional capacities. The IHR,
fundamentally revised in the aftermath of SARS-1, exposed gaps in global governance,
including: (1) China’s failure to notify WHO promptly of a widely circulating novel coronavirus in
Wuhan and WHO’s inability to independently verify state reports; (2) weak WHO compliance
mechanisms to enforce IHR obligations and its own recommendations; (3) WHO’s lack of power
to monitor, investigate, and remediate harmful actions; (4) insufficient transparency and
international exchange of scientific data; and (5) lack of global cooperation, especially in the
equitable allocation of vaccines and other medical resources.
Even the most basic investigations, such as to ascertain SARS-CoV-2’s origins, have thus far
proved unsuccessful. Perhaps most important, two-thirds of countries do not have IHR core
health systems capacities to detect and alert the global community about novel outbreaks,
including communications, surveillance, and response.
Legal Options for WHO and the United Nations
1

While WHO and the IHR have been the focus of global attention, the United Nations has
extensive power and experience in negotiating large-scale treaties such as the Framework
Convention on Climate Change and the Convention on the Rights of Persons with Disabilities.
The Global Preparedness Monitoring Board, convened by WHO and the World Bank,
recommended a pandemic treaty under UN auspices. The UN has comparative advantages,
including its multisectoral approach (climate, food, animal health), enhanced compliance
capabilities, and the ability to raise pandemic preparedness to the highest levels of
government. The UN also has wide experience in financing, supply chain management, and
humanitarian response, all vital during a global health emergency.
The WHA envisaged a WHO instrument, as the leading UN specialized agency for health. WHO
has broad constitutional authority to adopt regulations under Article 21, such as the IHR. The
Assembly could renegotiate those regulations, but the IHR has limited scope, and weak
compliance. WHO can adopt also a convention or agreement under Article 19, which it has
done only once, for the Framework Convention on Tobacco Control. A Framework Convention
grants countries wide flexibility, enabling consensus on broad principles of global health
security that can be strengthened over time with detailed protocols.
The United States has expressed interest in heightened transparency and accountability
through a non-binding agreement as opposed to a new treaty.4 Article 23 empowers the WHA
to adopt non-binding recommendations, which has created important global health norms,
such as on the marketing of infant formula and the international recruitment of healthcare
workers. The Organization has also negotiated the Pandemic Influenza Preparedness (PIP)
Framework to facilitate equitable sharing of pathogens for novel influenza viruses. Under the
PIP Framework, pharmaceutical companies and laboratories committed to real-time production
of vaccines, or other contributions, to benefit poorer countries.
The United Nations system, including WHO, has broad authority to create powerful norms and
compliance mechanisms to strengthen global health security, with choices ranging from
revising the IHR and adopting a framework convention through to non-binding
recommendations or instruments.
Core Content for an International Instrument
The potential breadth of pandemic prevention and preparedness is wide-ranging and
negotiations among 194 WHO member states will be challenging. Responding to vast gaps in
the COVID-19 pandemic response should include:5
Zoonotic Spillovers. The IHR focuses on response to novel outbreaks after they occur. A
new instrument could focus also on prevention of naturally occurring zoonoses, responsible for
an estimated 75 percent of new human diseases. Separating animal and human populations
could prevent spillovers, such as through land management, reforestation, and the effective
regulation of wild animal trade and markets. Researchers have already generated predictive
models to identify where spillovers are likely.6
2

Biosecurity and Biosafety. While SARS-CoV-2 most likely occurred in nature, a laboratory
leak at the Wuhan Institute of Virology is an alternative theory of the virus’ origin. Rigorous
regulation and inspection of laboratory safety, as well as gain-of-function research, could help
prevent unintentional or deliberate release of novel pathogens. WHO has issued international
guidance on biosafety that could be incorporated into a new agreement.7
Monitoring, Inspection and Compliance. Responding to weak IHR compliance and
accountability mechanisms, a new international instrument should enhance WHO or UN
authority and legitimacy to independently verify state reports, publish crucial outbreak data
without state confirmation, investigate novel outbreaks, and institute remedial actions. Norms
are only effective if they are implemented at the national and local level in a fully transparent
and cooperative manner.
Research, Scientific Sharing and Transparency. Undoubtedly the pandemic’s greatest
success came with the rapid development of vaccines and therapeutics, including with
innovative mRNA technologies. Yet, open access and sharing of real-time virus samples,
genomic sequencing, clinical trial and other research data and tools were often lacking. A new
legal instrument could channel significant research funding, while promoting open access, full
transparency, public/private partnerships, and scientific cooperation.
Health Systems. Underpinning rapid and effective response to novel pathogens requires
robust health system capacities, including human resources, surveillance, laboratories, and risk
communication. Capacities for testing, contact tracing, and vaccinating populations are crucial.
Clinics, community health workers, and hospitals are needed to care for and treat patients
during spikes in serious disease, as well as meeting everyday needs such as childhood
vaccinations, maternal care, and caring for patients with non-communicable diseases. An
international agreement could address states’ failures to comply with Article 44 of the IHR,
which calls for international technical and financial assistance to strengthen national public
health capacities.8
Domestic and International Equity. The COVID-19 pandemic revealed cavernous divides
based on race, gender, disability, and socioeconomic status both in the disproportionate
numbers of hospitalizations and deaths and in access essential medical countermeasures. Highincome countries dominated the global market in diagnostics, PPE, therapeutics and especially
vaccines. WHO and partners designed the ACT-Accelerator to accelerate development,
production, and equitable access to COVID-19 tests, treatments, and vaccines. Yet, as of
September 3rd, COVAX (the ACT-Accelerator’s vaccine pillar) had shipped only 236 million
COVID-19 vaccines to 139 countries, leaving most lower-income health workers and vulnerable
populations unprotected.9 Any new international agreement must plan for adequate supplies of
medical resources and equitable allocation among countries. This could include securing supply
chains, intellectual property waivers, knowledge-sharing and technology transfers, along with
ample donation of supplies.10
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The compound health, economic, social, and humanitarian crises caused by the novel
coronavirus, SARS-CoV-2, provides a compelling justification for a new international agreement
on pandemic prevention and preparedness. It is possible to significantly reduce the likelihood of
future novel outbreaks and to fortify the response through international cooperation, an
empowered and well-funded WHO, and strong domestic health systems.
Disclosures: The authors, along with Kevin A. Klock of the Foundation for the National Institutes
of Health (FNIH), are leading the O’Neill Institute/FNIH project on an international instrument
for pandemic prevention and preparedness. The Foundation provided funding for the project.
Prof. Gostin is Director of the WHO Collaborating Center on National and Global Health Law.
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